Aptamer Details

Back to Search Results

GBN2 (ID# 8110)

Nervous necrosis virus (NNV)
27.96 nM (reported value)
5 g/L glucose,10% FBS, 1.0 g/L bovine serum albumin, 0.1 mg/ml yeast tRNA and 5 mM MgCl2
NA If the oligo is a known aptamer sequence: For binding studies, perform a refolding protocol to ensure proper function (i.e. binding to antigen or target). Refer to the aptamer reference source for the appropriate refolding parameters and binding conditions. Note: it is unknown whether aptamer functions properly without refolding.

Note: Information on this aptamer oligo was obtained from the literature and hasn't been validated by Aptagen.

Zhou L, Wang S, Yu Q, et al. Characterization of Novel Aptamers Specifically Directed to Red-Spotted Grouper Nervous Necrosis Virus (RGNNV)-Infected Cells for Mediating Targeted siRNA Delivery. Front Microbiol. 2020;11:660. Published 2020 Apr 30. doi:10.3389/fmicb.2020.00660

Have your aptamer oligo synthesized ORDER